Quick Answer
Bluejay Diagnostics, Inc. reported Shares Outstanding of 604.5 thousand shares for fiscal year 2025.
Bluejay Diagnostics, Inc. Shares Outstanding — Annual History
| Fiscal Year | Shares Outstanding | YoY Change |
|---|---|---|
| 2025 | 604,534 | +336.5% |
| 2024 | 138,503 | +4370.7% |
| 2023 | 3,098 | -99.7% |
| 2022 | 1.01M | -95.0% |
| 2021 | 20.11M | +539.1% |
| 2020 | 3.15M | — |
Quarterly Shares Outstanding
| Quarter Ending | Shares Outstanding | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | 1.64M | -90.8% | +9.7% |
| June 30, 2025 | 1.49M | -42.2% | +169.7% |
| March 31, 2025 | 554,012 | -79.4% | +0.0% |
| December 31, 2024 | 554,012 | +257.7% | -96.9% |
| September 30, 2024 | 17.83M | +1338.7% | +589.9% |
| June 30, 2024 | 2.58M | +152.5% | -3.9% |
| March 31, 2024 | 2.69M | -86.9% | +1635.7% |
| December 31, 2023 | 154,893 | -84.7% | -87.5% |
- Bluejay Diagnostics, Inc. showed an increase of +336.5% in Shares Outstanding compared to the prior fiscal year.
- Over the 2020–2025 period, Bluejay Diagnostics, Inc.’s shares outstanding has declined by 80.8% (from 3.15 million shares to 604.5 thousand shares).
- The most recent figure is from Bluejay Diagnostics, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 6, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: